JP2022505663A5 - - Google Patents
Info
- Publication number
- JP2022505663A5 JP2022505663A5 JP2021522078A JP2021522078A JP2022505663A5 JP 2022505663 A5 JP2022505663 A5 JP 2022505663A5 JP 2021522078 A JP2021522078 A JP 2021522078A JP 2021522078 A JP2021522078 A JP 2021522078A JP 2022505663 A5 JP2022505663 A5 JP 2022505663A5
- Authority
- JP
- Japan
- Prior art keywords
- binding
- fragment
- domain
- receptor
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749429P | 2018-10-23 | 2018-10-23 | |
| US62/749,429 | 2018-10-23 | ||
| PCT/US2019/057702 WO2020086745A1 (en) | 2018-10-23 | 2019-10-23 | MULTIVALENT IgM- AND IgA-Fc-BASED BINDING MOLECULES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022505663A JP2022505663A (ja) | 2022-01-14 |
| JP2022505663A5 true JP2022505663A5 (cg-RX-API-DMAC7.html) | 2022-10-28 |
Family
ID=70331240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522078A Pending JP2022505663A (ja) | 2018-10-23 | 2019-10-23 | IgM-Fcベース及びIgA-Fcベースの多価結合分子 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210380701A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3870223A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022505663A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210083260A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112839677A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019368289A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3113268A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL281901A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021004660A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202103720XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020086745A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015120474A1 (en) | 2014-02-10 | 2015-08-13 | Igm Biosciences, Inc. | Iga multi-specific binding molecules |
| EP4011910A1 (en) | 2014-04-03 | 2022-06-15 | IGM Biosciences, Inc. | Modified j-chain |
| PT3247728T (pt) | 2015-01-20 | 2020-07-16 | Igm Biosciences Inc | Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas |
| KR102357312B1 (ko) | 2015-03-04 | 2022-02-03 | 아이쥐엠 바이오사이언스 인코포레이티드 | Cd20 결합 분자 및 그의 용도 |
| WO2016154593A1 (en) | 2015-03-25 | 2016-09-29 | Igm Biosciences, Inc. | Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
| AU2016249404B2 (en) | 2015-04-17 | 2021-01-21 | Igm Biosciences, Inc. | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof |
| PT3355913T (pt) | 2015-09-30 | 2024-12-18 | Igm Biosciences Inc | Moléculas de ligação com cadeia j modificada |
| ES2819870T3 (es) | 2015-09-30 | 2021-04-19 | Igm Biosciences Inc | Moléculas de unión con cadena J modificada |
| WO2017196867A1 (en) | 2016-05-09 | 2017-11-16 | Igm Biosciences, Inc. | Anti-pd-l1 antibodies |
| CA3055790A1 (en) | 2017-04-07 | 2018-10-11 | Igm Biosciences, Inc. | Modified human igm constant regions for modulation of complement-dependent cytolysis effector function |
| CN111787951B (zh) | 2018-03-01 | 2025-06-17 | Igm生物科学股份有限公司 | 影响IgM血清半衰期的IgM Fc和J链突变 |
| JP2022544405A (ja) | 2019-08-15 | 2022-10-18 | アイジーエム バイオサイエンシズ インコーポレイテッド | 免疫刺激性多量体型結合分子 |
| US11857620B2 (en) | 2020-03-11 | 2024-01-02 | Immunitybio, Inc. | Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus |
| US20210284716A1 (en) | 2020-03-11 | 2021-09-16 | Immunitybio, Inc. | ACE2-Fc Trap |
| US12285480B2 (en) | 2020-03-11 | 2025-04-29 | Nantcell, Inc. | Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses |
| JP2023522962A (ja) * | 2020-04-22 | 2023-06-01 | アイジーエム バイオサイエンシズ インコーポレイテッド | Pd-1アゴニスト多量体結合分子 |
| CN116813759B (zh) * | 2022-03-21 | 2025-11-28 | 中国科学院微生物研究所 | 纳米抗体r14的构建体及其应用 |
| CA3245061A1 (en) * | 2022-04-07 | 2023-10-12 | Repertoire Immune Medicines, Inc. | T-CELL RECEIVER MULTIMERS AND THEIR USES |
| CN118369336A (zh) * | 2022-04-15 | 2024-07-19 | Im生技股份有限公司 | 具有改进半衰期的融合蛋白平台 |
| US20240025996A1 (en) * | 2022-07-11 | 2024-01-25 | Fred Hutchinson Cancer Center | Igm-multimerized single-domain antibodies that bind ror1 |
| CN117466996A (zh) * | 2022-07-29 | 2024-01-30 | 深圳市新产业生物医学工程股份有限公司 | 新型冠状病毒检测试剂盒及应用 |
| WO2024073700A2 (en) * | 2022-09-30 | 2024-04-04 | Igm Biosciences, Inc. | Methods of treating autoimmune disorders using multimeric anti-cd20/anti-cd3 antibodies |
| CN119505007A (zh) * | 2023-08-23 | 2025-02-25 | 菲鹏生物股份有限公司 | 免疫球蛋白Fc区或恒定区 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997047732A2 (en) * | 1996-06-14 | 1997-12-18 | Smithkline Beecham Corporation | Hexameric fusion proteins and uses therefor |
| PL2604693T3 (pl) * | 2008-07-21 | 2016-09-30 | Jednołańcuchowe cząsteczki TNFSF | |
| EP2760891B1 (en) * | 2011-09-26 | 2018-11-07 | JN Biosciences LLC | Hybrid constant regions |
| WO2015120474A1 (en) * | 2014-02-10 | 2015-08-13 | Igm Biosciences, Inc. | Iga multi-specific binding molecules |
| PT3247728T (pt) * | 2015-01-20 | 2020-07-16 | Igm Biosciences Inc | Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas |
| KR102357312B1 (ko) * | 2015-03-04 | 2022-02-03 | 아이쥐엠 바이오사이언스 인코포레이티드 | Cd20 결합 분자 및 그의 용도 |
| WO2016154593A1 (en) * | 2015-03-25 | 2016-09-29 | Igm Biosciences, Inc. | Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
| US20190330374A1 (en) * | 2016-07-20 | 2019-10-31 | Igm Biosciences, Inc. | Multimeric ox40 binding molecules and uses thereof |
| CA3030659A1 (en) * | 2016-07-20 | 2018-01-25 | Igm Biosciences, Inc. | Multimeric gitr binding molecules and uses thereof |
| CA3055790A1 (en) * | 2017-04-07 | 2018-10-11 | Igm Biosciences, Inc. | Modified human igm constant regions for modulation of complement-dependent cytolysis effector function |
-
2019
- 2019-10-23 AU AU2019368289A patent/AU2019368289A1/en not_active Abandoned
- 2019-10-23 KR KR1020217011641A patent/KR20210083260A/ko not_active Ceased
- 2019-10-23 EP EP19875608.2A patent/EP3870223A4/en not_active Withdrawn
- 2019-10-23 JP JP2021522078A patent/JP2022505663A/ja active Pending
- 2019-10-23 US US17/287,828 patent/US20210380701A1/en not_active Abandoned
- 2019-10-23 WO PCT/US2019/057702 patent/WO2020086745A1/en not_active Ceased
- 2019-10-23 SG SG11202103720XA patent/SG11202103720XA/en unknown
- 2019-10-23 MX MX2021004660A patent/MX2021004660A/es unknown
- 2019-10-23 CN CN201980067597.2A patent/CN112839677A/zh active Pending
- 2019-10-23 CA CA3113268A patent/CA3113268A1/en active Pending
-
2021
- 2021-03-30 IL IL281901A patent/IL281901A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20210083260A (ko) | 다가 IgM- 및 IgA-Fc 기반 결합 분자 | |
| US11572388B2 (en) | Chimeric polypeptides and uses thereof | |
| CN107428830B (zh) | 单体fc结构域 | |
| JP2022504822A5 (cg-RX-API-DMAC7.html) | ||
| WO2020142625A4 (en) | Compositions for increasing half-life of a therapeutic agent in canines and methods of use | |
| CN118852460A (zh) | 具有非FcγR依赖性激动活性的肿瘤坏死因子(TNF)受体超家族(TNFRSF)受体-激活抗体融合蛋白(具有非FcγR依赖性激动活性的TNFRSF受体-激活抗体融合蛋白;TRAAFFIAA) | |
| JP2024504728A5 (cg-RX-API-DMAC7.html) | ||
| RU2020118832A (ru) | Биспецифические слитые полипептиды и способы их применения | |
| US20230045794A1 (en) | Nk cell-directed chimeric proteins | |
| US12448465B2 (en) | Peptides | |
| JP2022548112A5 (cg-RX-API-DMAC7.html) | ||
| KR20240024858A (ko) | sPD-1과 IL-15를 갖는 이중특이적 Fc 융합 단백질 | |
| JP2023538902A (ja) | 操作されたリガンドを使用する材料及び方法 | |
| CN115724984A (zh) | 自身免疫b细胞消除剂分子及其用途 | |
| US20260049118A1 (en) | Single-chain chimeric polypeptides and uses thereof | |
| US20260132185A1 (en) | Multi-chain chimeric polypeptides and uses thereof | |
| WO2022262832A1 (zh) | 双特异性融合蛋白 | |
| RU2021131461A (ru) | Биспецифичный слитый белок и его применение | |
| RU2023135094A (ru) | ВАРИАНТ Fc С ПОВЫШЕННОЙ АФФИННОСТЬЮ К Fc-РЕЦЕПТОРАМ И УЛУЧШЕННОЙ ТЕРМИЧЕСКОЙ СТАБИЛЬНОСТЬЮ |